These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23570194)

  • 1. Imaging drug action in schizophrenia: research update.
    Laruelle M; Abi-Dargham A
    Eur Psychiatry; 2003 Dec; 18 Suppl 2():32s-37s. PubMed ID: 23570194
    [No Abstract]   [Full Text] [Related]  

  • 2. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions.
    Jin GZ; Zhu ZT; Fu Y
    Trends Pharmacol Sci; 2002 Jan; 23(1):4-7. PubMed ID: 11804640
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional neuroimaging in schizophrenia: diagnosis and drug discovery.
    McGuire P; Howes OD; Stone J; Fusar-Poli P
    Trends Pharmacol Sci; 2008 Feb; 29(2):91-8. PubMed ID: 18187211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia.
    Sjøholm H; Bratlid T; Sundsfjord J
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):27-31. PubMed ID: 14712338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local effects of acute ethanol on dopamine neurotransmission in the ventral striatum in C57BL/6 mice.
    Budygin EA; Mathews TA; Lapa GB; Jones SR
    Eur J Pharmacol; 2005 Oct; 523(1-3):40-5. PubMed ID: 16226738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.
    Geaney DP; Ellis PM; Soper N; Shepstone BJ; Cowen PJ
    Biol Psychiatry; 1992 Aug; 32(3):293-5. PubMed ID: 1358229
    [No Abstract]   [Full Text] [Related]  

  • 10. The unique effect of remoxipride on dopamine utilization in the basal ganglia.
    Fuxe K; Ogren SO
    Acta Physiol Scand; 1991 Apr; 141(4):577-8. PubMed ID: 1678908
    [No Abstract]   [Full Text] [Related]  

  • 11. Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats.
    Wydra K; Golembiowska K; Zaniewska M; Kamińska K; Ferraro L; Fuxe K; Filip M
    Addict Biol; 2013 Mar; 18(2):307-24. PubMed ID: 23311632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroreceptor imaging in psychiatric disorders.
    Frankle WG; Laruelle M
    Ann Nucl Med; 2002 Nov; 16(7):437-46. PubMed ID: 12508833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress.
    Brunelin J; d'Amato T; Van Os J; Costes N; Suaud Chagny MF; Saoud M
    Psychiatry Res; 2010 Feb; 181(2):130-5. PubMed ID: 20080396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensory stimulation accelerates dopamine release in the basal ganglia.
    Inoue M; Katsumi Y; Hayashi T; Mukai T; Ishizu K; Hashikawa K; Saji H; Fukuyama H
    Brain Res; 2004 Nov; 1026(2):179-84. PubMed ID: 15488479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia related to quetiapine and confirmed by a DAT scan.
    Chatziioannou SN; Rizos EN; Kallergi M; Douzenis A; Apostolopoulos A; Bacalis S; Lykouras L
    J Clin Psychopharmacol; 2011 Aug; 31(4):535-8. PubMed ID: 21720231
    [No Abstract]   [Full Text] [Related]  

  • 16. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Neuroimaging in Social Anxiety Disorder: A Review.
    Doruyter AG; Dupont P; Stein DJ; Lochner C; Warwick JM
    J Nucl Med; 2018 Dec; 59(12):1794-1800. PubMed ID: 30291197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemistry of schizophrenia: the contribution of neuroimaging postmortem pathology and neurochemistry in schizophrenia.
    Dean B
    Curr Top Med Chem; 2012; 12(21):2375-92. PubMed ID: 23279177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study.
    Majuri J; Joutsa J; Arponen E; Forsback S; Kaasinen V
    Neuroimage; 2018 Dec; 183():1-6. PubMed ID: 30077742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens.
    Devaud LL; Hollingsworth EB
    Eur J Pharmacol; 1991 Jan; 192(3):427-9. PubMed ID: 1675992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.